Medical - Devices
Compare Stocks
2 / 10Stock Comparison
FONR vs PHG
Revenue, margins, valuation, and 5-year total return — side by side.
Medical - Devices
FONR vs PHG — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Medical - Devices | Medical - Devices |
| Market Cap | $124M | $25.84B |
| Revenue (TTM) | $106M | $17.83B |
| Net Income (TTM) | $8M | $895M |
| Gross Margin | 40.8% | 45.2% |
| Operating Margin | 10.1% | 8.0% |
| Forward P/E | 15.3x | 17.5x |
| Total Debt | $39M | $8.09B |
| Cash & Equiv. | $56M | $2.79B |
FONR vs PHG — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| FONAR Corporation (FONR) | 100 | 79.0 | -21.0% |
| Koninklijke Philips… (PHG) | 100 | 65.9 | -34.1% |
Price return only. Dividends and distributions are not included.
Quick Verdict: FONR vs PHG
Each card shows where this stock fits in a portfolio — not just who wins on paper.
FONR carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.
- Dividend streak 0 yrs, beta 0.10
- Rev growth 1.4%, EPS growth -19.6%, 3Y rev CAGR 2.3%
- Lower volatility, beta 0.10, Low D/E 24.3%, current ratio 8.45x
PHG is the clearest fit if your priority is long-term compounding.
- 48.3% 10Y total return vs FONR's 35.0%
- 1.5% yield; 1-year raise streak; the other pay no meaningful dividend
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 1.4% revenue growth vs PHG's -1.0% | |
| Value | Lower P/E (15.3x vs 17.5x) | |
| Quality / Margins | 7.1% margin vs PHG's 5.0% | |
| Stability / Safety | Beta 0.10 vs PHG's 1.12, lower leverage | |
| Dividends | 1.5% yield; 1-year raise streak; the other pay no meaningful dividend | |
| Momentum (1Y) | +53.4% vs PHG's +17.7% | |
| Efficiency (ROA) | 3.5% ROA vs PHG's 3.4%, ROIC 6.1% vs 6.4% |
FONR vs PHG — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
FONR vs PHG — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
FONR leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
PHG is the larger business by revenue, generating $17.8B annually — 168.2x FONR's $106M. Profitability is closely matched — net margins range from 7.1% (FONR) to 5.0% (PHG).
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $106M | $17.8B |
| EBITDAEarnings before interest/tax | $15M | $2.5B |
| Net IncomeAfter-tax profit | $8M | $895M |
| Free Cash FlowCash after capex | $6M | $755M |
| Gross MarginGross profit ÷ Revenue | +40.8% | +45.2% |
| Operating MarginEBIT ÷ Revenue | +10.1% | +8.0% |
| Net MarginNet income ÷ Revenue | +7.1% | +5.0% |
| FCF MarginFCF ÷ Revenue | +5.4% | +4.2% |
| Rev. Growth (YoY)Latest quarter vs prior year | +2.4% | +1.1% |
| EPS Growth (YoY)Latest quarter vs prior year | +6.9% | +2.1% |
Valuation Metrics
FONR leads this category, winning 5 of 5 comparable metrics.
Valuation Metrics
At 15.3x trailing earnings, FONR trades at a 38% valuation discount to PHG's 24.9x P/E. On an enterprise value basis, FONR's 6.5x EV/EBITDA is more attractive than PHG's 10.7x.
| Metric | ||
|---|---|---|
| Market CapShares × price | $124M | $25.8B |
| Enterprise ValueMkt cap + debt − cash | $106M | $32.1B |
| Trailing P/EPrice ÷ TTM EPS | 15.35x | 24.85x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 17.55x |
| PEG RatioP/E ÷ EPS growth rate | — | — |
| EV / EBITDAEnterprise value multiple | 6.52x | 10.70x |
| Price / SalesMarket cap ÷ Revenue | 1.19x | 1.23x |
| Price / BookPrice ÷ Book value/share | 0.77x | 2.02x |
| Price / FCFMarket cap ÷ FCF | 16.61x | 24.62x |
Profitability & Efficiency
FONR leads this category, winning 5 of 8 comparable metrics.
Profitability & Efficiency
PHG delivers a 8.2% return on equity — every $100 of shareholder capital generates $8 in annual profit, vs $4 for FONR. FONR carries lower financial leverage with a 0.24x debt-to-equity ratio, signaling a more conservative balance sheet compared to PHG's 0.74x.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | +4.3% | +8.2% |
| ROA (TTM)Return on assets | +3.5% | +3.4% |
| ROICReturn on invested capital | +6.1% | +6.4% |
| ROCEReturn on capital employed | +5.9% | +7.1% |
| Piotroski ScoreFundamental quality 0–9 | 7 | 7 |
| Debt / EquityFinancial leverage | 0.24x | 0.74x |
| Net DebtTotal debt minus cash | -$17M | $5.3B |
| Cash & Equiv.Liquid assets | $56M | $2.8B |
| Total DebtShort + long-term debt | $39M | $8.1B |
| Interest CoverageEBIT ÷ Interest expense | 705.24x | 4.34x |
Total Returns (Dividends Reinvested)
Evenly matched — FONR and PHG each lead in 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in FONR five years ago would be worth $10,983 today (with dividends reinvested), compared to $5,734 for PHG. Over the past 12 months, FONR leads with a +53.4% total return vs PHG's +17.7%. The 3-year compound annual growth rate (CAGR) favors PHG at 11.6% vs FONR's 4.6% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | +1.9% | +0.3% |
| 1-Year ReturnPast 12 months | +53.4% | +17.7% |
| 3-Year ReturnCumulative with dividends | +14.3% | +38.8% |
| 5-Year ReturnCumulative with dividends | +9.8% | -42.7% |
| 10-Year ReturnCumulative with dividends | +35.0% | +48.3% |
| CAGR (3Y)Annualised 3-year return | +4.6% | +11.6% |
Risk & Volatility
FONR leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
FONR is the less volatile stock with a 0.10 beta — it tends to amplify market swings less than PHG's 1.12 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. FONR currently trades 99.6% from its 52-week high vs PHG's 81.2% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.10x | 1.12x |
| 52-Week HighHighest price in past year | $18.95 | $33.44 |
| 52-Week LowLowest price in past year | $12.17 | $21.95 |
| % of 52W HighCurrent price vs 52-week peak | +99.6% | +81.2% |
| RSI (14)Momentum oscillator 0–100 | 67.7 | 47.7 |
| Avg Volume (50D)Average daily shares traded | 52K | 1.0M |
Analyst Outlook
PHG leads this category, winning 1 of 1 comparable metric.
Analyst Outlook
PHG is the only dividend payer here at 1.47% yield — a key consideration for income-focused portfolios.
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Hold |
| Price TargetConsensus 12-month target | — | — |
| # AnalystsCovering analysts | — | 22 |
| Dividend YieldAnnual dividend ÷ price | — | +1.5% |
| Dividend StreakConsecutive years of raises | 0 | 1 |
| Dividend / ShareAnnual DPS | — | $0.34 |
| Buyback YieldShare repurchases ÷ mkt cap | +1.5% | 0.0% |
FONR leads in 4 of 6 categories (Income & Cash Flow, Valuation Metrics). PHG leads in 1 (Analyst Outlook). 1 tied.
FONR vs PHG: Frequently Asked Questions
9 questions · data-driven answers · updated daily
01Is FONR or PHG a better buy right now?
For growth investors, FONAR Corporation (FONR) is the stronger pick with 1.
4% revenue growth year-over-year, versus -1. 0% for Koninklijke Philips N. V. (PHG). FONAR Corporation (FONR) offers the better valuation at 15. 3x trailing P/E, making it the more compelling value choice. Analysts rate Koninklijke Philips N. V. (PHG) a "Hold" — based on 22 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — FONR or PHG?
On trailing P/E, FONAR Corporation (FONR) is the cheapest at 15.
3x versus Koninklijke Philips N. V. at 24. 9x.
03Which is the better long-term investment — FONR or PHG?
Over the past 5 years, FONAR Corporation (FONR) delivered a total return of +9.
8%, compared to -42. 7% for Koninklijke Philips N. V. (PHG). Over 10 years, the gap is even starker: PHG returned +48. 3% versus FONR's +35. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — FONR or PHG?
By beta (market sensitivity over 5 years), FONAR Corporation (FONR) is the lower-risk stock at 0.
10β versus Koninklijke Philips N. V. 's 1. 12β — meaning PHG is approximately 971% more volatile than FONR relative to the S&P 500. On balance sheet safety, FONAR Corporation (FONR) carries a lower debt/equity ratio of 24% versus 74% for Koninklijke Philips N. V. — giving it more financial flexibility in a downturn.
05Which is growing faster — FONR or PHG?
By revenue growth (latest reported year), FONAR Corporation (FONR) is pulling ahead at 1.
4% versus -1. 0% for Koninklijke Philips N. V. (PHG). On earnings-per-share growth, the picture is similar: Koninklijke Philips N. V. grew EPS 224. 0% year-over-year, compared to -19. 6% for FONAR Corporation. Over a 3-year CAGR, FONR leads at 2. 3% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — FONR or PHG?
FONAR Corporation (FONR) is the more profitable company, earning 8.
0% net margin versus 5. 0% for Koninklijke Philips N. V. — meaning it keeps 8. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: FONR leads at 11. 1% versus 8. 0% for PHG. At the gross margin level — before operating expenses — FONR leads at 81. 7%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Which pays a better dividend — FONR or PHG?
In this comparison, PHG (1.
5% yield) pays a dividend. FONR does not pay a meaningful dividend and should not be held primarily for income.
08Is FONR or PHG better for a retirement portfolio?
For long-horizon retirement investors, FONAR Corporation (FONR) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
10)). Both have compounded well over 10 years (FONR: +35. 0%, PHG: +48. 3%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
09What are the main differences between FONR and PHG?
Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: FONR is a small-cap deep-value stock; PHG is a mid-cap quality compounder stock. PHG pays a dividend while FONR does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.